BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23408900)

  • 1. Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-β signaling.
    Achyut BR; Bader DA; Robles AI; Wangsa D; Harris CC; Ried T; Yang L
    PLoS Genet; 2013; 9(2):e1003251. PubMed ID: 23408900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reciprocal role of prostate cancer on stromal DNA damage.
    Banerjee J; Mishra R; Li X; Jackson RS; Sharma A; Bhowmick NA
    Oncogene; 2014 Oct; 33(41):4924-31. PubMed ID: 24141771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
    Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
    Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
    Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.
    Cohen J; Chen Z; Lu SL; Yang XP; Arun P; Ehsanian R; Brown MS; Lu H; Yan B; Diallo O; Wang XJ; Van Waes C
    Cancer Res; 2009 Apr; 69(8):3415-24. PubMed ID: 19351843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia.
    Guasch G; Schober M; Pasolli HA; Conn EB; Polak L; Fuchs E
    Cancer Cell; 2007 Oct; 12(4):313-27. PubMed ID: 17936557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
    Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
    Cancer Res; 2007 May; 67(10):4869-77. PubMed ID: 17495323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
    Li X; Sterling JA; Fan KH; Vessella RL; Shyr Y; Hayward SW; Matrisian LM; Bhowmick NA
    Mol Cancer Res; 2012 Apr; 10(4):494-503. PubMed ID: 22290877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
    Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
    Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling.
    Li X; Wang Y; Sharif-Afshar AR; Uwamariya C; Yi A; Ishii K; Hayward SW; Matusik RJ; Bhowmick NA
    Differentiation; 2009 Jan; 77(1):95-102. PubMed ID: 19281768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.
    Fang WB; Jokar I; Chytil A; Moses HL; Abel T; Cheng N
    Clin Exp Metastasis; 2011 Apr; 28(4):351-66. PubMed ID: 21374085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMP7 Signaling in
    Eikesdal HP; Becker LM; Teng Y; Kizu A; Carstens JL; Kanasaki K; Sugimoto H; LeBleu VS; Kalluri R
    Mol Cancer Res; 2018 Oct; 16(10):1568-1578. PubMed ID: 29934328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
    Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
    Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer induced by loss of Apc is restrained by TGFβ signaling.
    Bjerke GA; Pietrzak K; Melhuish TA; Frierson HF; Paschal BM; Wotton D
    PLoS One; 2014; 9(3):e92800. PubMed ID: 24651496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks.
    Cheng N; Bhowmick NA; Chytil A; Gorksa AE; Brown KA; Muraoka R; Arteaga CL; Neilson EG; Hayward SW; Moses HL
    Oncogene; 2005 Jul; 24(32):5053-68. PubMed ID: 15856015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.
    Bhowmick NA; Chytil A; Plieth D; Gorska AE; Dumont N; Shappell S; Washington MK; Neilson EG; Moses HL
    Science; 2004 Feb; 303(5659):848-51. PubMed ID: 14764882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype.
    Bharathy S; Xie W; Yingling JM; Reiss M
    Cancer Res; 2008 Mar; 68(6):1656-66. PubMed ID: 18339844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
    Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
    Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis.
    Li X; Placencio V; Iturregui JM; Uwamariya C; Sharif-Afshar AR; Koyama T; Hayward SW; Bhowmick NA
    Oncogene; 2008 Nov; 27(56):7118-30. PubMed ID: 18724388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.